by Arjun Walia, The Pulse:
In a new study published on January 3, 2023, in the journal Circulation, the authors describe how “free spike antigen” was “detected in blood of adolescents & young adults who developed post-mRNA vaccine myocarditis, advancing insight into potential underlying cause” of vaccine induced myocarditis.
The researchers collected blood from 16 patients who were hospitalized at Massachusetts General for Children or Boston Children’s Hospital for myocarditis shortly after COVID-19 vaccination. Collection was done from January 2021 through February 2022, and their results were compared with those from 45 healthy, asymptomatic, age-matched vaccinated control subjects.
TRUTH LIVES on at https://sgtreport.tv/
The spike protein was detected in the blood of adolescents and young adults who developed post-mRNA vaccine myocarditis, but not in the healthy control subjects who didn’t.
“A notable finding was that markedly elevated levels of full-length spike protein (33.9±22.4 pg/mL), unbound by antibodies, were detected in the plasma of individuals with postvaccine myocarditis, whereas no free spike was detected in asymptomatic vaccinated control subjects (unpaired t test; P<0.0001).”
This study, among others, begs the question, what happens after vaccination? What are the mechanisms of action? Where do the contents of the vaccine go and what do they do inside of the body? Why is what happens different for each person? Do the vaccine contents simply stay at the injection site, or do they travel elsewhere? And if they travel elsewhere, are there potential health consequences associated with that?
We are told that it’s simple, that mRNA vaccines simply give your cells instructions for how to make the spike protein found on the surface of the COVID-19 virus. After vaccination, your muscle cells begin making the spike protein pieces and displaying them on cell surfaces. This causes your body to create antibodies against the virus.
This may be true for some, but evidence continues to suggest it’s not as simple as we’ve been told. The findings of this new study may be key to understanding as to why serious vaccine injuries, including death, are being reported in record amounts.
We’re Talking About ‘Bio-Distribution‘
Bio-distribution studies are a standard practice of drug safety testing. But given the rush and ‘speed-up’ of the production of COVID-19 mRNA vaccines, normal safety testing and the usual long term studies were not able to be conducted. In essence, the human race became one giant human clinical trial – even though that’s a controversial statement to make.
As early as May 2021, Pfizer and Moderna did not respond to The British Medical Journal (BMJ) and their questions regarding why no bio-distribution studies were conducted on their mRNA products. According to a piece written by Dr. Peter Doshi, Senior Editor at the British Medical Journal,
“None of the companies, or the FDA, would say whether new bio distribution studies will be required prior to licensure.”
When I first read this I was quite concerned, because mRNA molecules have been deliberately manipulated to become more stable once inside the cell. A “pseudouridine” molecule has been added to the mRNA to give it a longer half-life than normal mRNA. Therefore, the production of spike protein within the cell, of those who have been vaccinated, is not being turned off. The implications of this are not well understood, and it is unknown for how long spike protein production continues within the cell. This is a big deal.
The concerning thing about this is that studies, like the one above, show that spike protein can leak outside of the cell and enter into the blood stream. This is one possible way vaccine injuries, like myocarditis, are occurring.
Perhaps if appropriate bio-distribution studies were conduced this safety signal would have been recognized before mass deployment.
At the time the BMJ raised these concerns, a May 2021 study was published showing that spike protein could be detected in the blood of 11 of the 13 participants following vaccination with the Moderna mRNA vaccine.
A study by Röltgen et al. published in early 2022 found that the vaccine mRNA persists in the body up to 60 days, with 60 days being the end point of their study. It would be interesting to see a study up to one year post vaccination, but even 60 days is concerning.
A March 2022 study published in the journal Cell, showed that vaccine-derived spike protein and mRNA persist for up to two months in the germinal centres of lymph nodes.
During an autopsy of a vaccinated person that had died after mRNA vaccination, it was found that the vaccine disperses rapidly from the injection site and can be found in nearly all parts of the body. These findings were published in June 2021 in the International Journal of Infectious Diseases.
